Old Web
English
Sign In
Acemap
>
authorDetail
>
Ben Markman
Ben Markman
Alfred Hospital
Medicine
in patient
Cancer research
Monoclonal antibody
anti cd40
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study of AK119, an anti-CD73 monoclonal antibody, in combination with AK104, an anti-PD-1/CTLA-4 bispecific antibody, in patients with advanced or metastatic solid tumors.
2021
Journal of Clinical Oncology
Ben Markman
Amy Hsin-Chieh Hsieh
Jermaine Coward
Matteo S. Carlino
Sophia Frentzas
Xiaoping Jin
Baiyong Li
Zhongmin Maxwell Wang
Kon Yew Kwek
Yu Xia
Show All
Source
Cite
Save
Citations (0)
Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution.
2021
Siddharth Menon
Amy Davies
Sophia Frentzas
Cheryl-Ann Hawkins
Eva Segelov
Daphne Day
Ben Markman
Show All
Source
Cite
Save
Citations (0)
Phase I open-label, dose escalation of YH003, an anti-CD40 monoclonal antibody in combination with toripalimab (anti-PD-1 mAb) in patients with advanced solid tumors.
2021
Journal of Clinical Oncology
Jermaine Coward
A Abed
Adnan Nagrial
Ben Markman
Show All
Source
Cite
Save
Citations (0)
1